How can FDA be Improved? Patient Groups Offer Ideas
By Alexander Gaffney, RAC -
Published 10 December 2014
More than a dozen patient groups and trade associations are offering their advice to the US Food and Drug Administration (FDA) on ways the agency can improve its regulatory and administrative processes to take into account the views and expertise of patients and their advocates.
Categories: News, US, FDA
Tags: FDASIA, Patients, Patient Groups, Patient-Centered Drug Development, FDASIA Section 917, Recommendations for FDA